MAIN PLAYERS IN THE SYNGENTA DEAL

AstraZeneca

External advisers: Freshfields Bruckhaus Deringer, UK (Julian Long, David Higgins and Nick Spearing); Davis Polk & Wardwell, US (Paul Kumleben and Eric Dann in London, Ronan Harty in New York); Homburger, Switzerland (Claude Lambert)

In-house team for AstraZeneca: Graeme Musker, Shaun Grady, Tatjana May

In-house team for Zeneca Agrochemicals: Jonathan Sullivan, Lynton Boardman, Catherine Copping

Novartis

External advisers: Bär & Karrer, Switzerland (Rolf Watter and Ralph Malacrida); Shearman & Sterling, UK and US (Adrian Knight, Jim Bartos and Penny Pilzer)

In-house team for Novartis Corporate: Martin Henrich, Hans Fricker, Urs Barlocher

In-house team for Novartis Agribusiness: Christoph Mäder (now head of legal at Syngenta), Daniel Michaelisk, Damian Heller

Syngenta

External advisers: Cleary Gottlieb Steen & Hamilton, US (Meme Stowers and Laurent Alpert); Rowe & Maw, UK (Andrew Copley and Stephanie Bates)

Investment banks: Credit Suisse First Boston, UBS Warburg, Goldman Sachs, Morgan Stanley

External advisers: Linklaters & Alliance, UK (Chris Kelly and Greg Mully); Sullivan & Cromwell, US (John O'Conner and Oderisio de Vito Piscicelli)